Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits QuantWave Forecast Target with 22.06% Profit

August 08, 2023
ELI LILLY AND COMPANY (LLY) has successfully reached the price target forecasted by QuantWave, resulting in a profit of 22.06%. The forecast signal, issued on May 4, 2023, indicated a long position for the stock when it was priced at 420.35 $. On August 8, 2023, the stock hit the target price of 513.09 $ as predicted.

This achievement highlights the accuracy and effectiveness of the QuantWave analytics platform in providing valuable insights for investors. The successful forecast for ELI LILLY AND COMPANY demonstrates the platform's ability to identify profitable opportunities in the market based on data-driven analysis.

The stock movement of ELI LILLY AND COMPANY may have been influenced by various factors, such as positive developments in the pharmaceutical industry, company-specific news, or overall market trends. Whatever the underlying reasons, QuantWave's forecast proved to be on point, resulting in a significant gain for investors who followed the recommendation.

QuantWave offers a range of forecasts for various stocks, presenting users with the opportunity to capitalize on potential profits in the financial markets. For those interested in delving deeper into the investment strategies employed by QuantWave, QuantSchool provides a comprehensive educational framework that outlines the key principles for leveraging the platform's forecasting system effectively. By utilizing QuantWave's analytics and educational resources, investors can enhance their decision-making process and strive for consistent returns in their investment endeavors.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 20.49% Profit for QuantWave Users  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 20.49% for users who acted on the prediction....


VRTXJune 4, 2024VERTEX PHARMACEUTICALS Stock Hits Forecasted Price Target with 14.32% Profit: QuantWave Analysis  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....


VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits 10.2% Profit Target Forecast by QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, with a profit of 10.2% realized....